Cargando…

Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China

BACKGROUND: Bloodstream infections due to Candida species cause significant morbidity and mortality, and the epidemiology of Candida infection is changing. Surveillance for candidemia is necessary to detect trends in species distribution and antifungal resistance. METHODS: The medical and electronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Chun-fang, Li, Fang-qiu, Shi, Li-ning, Hu, Yu-an, Wang, Ying, Huang, Mei, Kong, Qian-qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723814/
https://www.ncbi.nlm.nih.gov/pubmed/23875950
http://dx.doi.org/10.1186/1471-2334-13-337
_version_ 1782278333357096960
author Ma, Chun-fang
Li, Fang-qiu
Shi, Li-ning
Hu, Yu-an
Wang, Ying
Huang, Mei
Kong, Qian-qian
author_facet Ma, Chun-fang
Li, Fang-qiu
Shi, Li-ning
Hu, Yu-an
Wang, Ying
Huang, Mei
Kong, Qian-qian
author_sort Ma, Chun-fang
collection PubMed
description BACKGROUND: Bloodstream infections due to Candida species cause significant morbidity and mortality, and the epidemiology of Candida infection is changing. Surveillance for candidemia is necessary to detect trends in species distribution and antifungal resistance. METHODS: The medical and electronic records of all patients who had candidemia at the authors’ hospital from 2009 to 2011 were reviewed for demographic data and clinical information, including the infecting Candida species, resistance to antifungals and survival, and the presence of risk factors associated with candidemia. RESULTS: A total of 133 distinct episodes of candidemia were identified over the study period. The annual incidence of candidemia ranged between 0.71 and 0.85 cases/1000 hospital discharges. The most frequent Candida species were C. tropicalis (28.6%), followed by C. albicans (23.3%) and C. parapsilosis (19.5%). The rates of susceptibility to antifungal agents were as followed: voriconazole (97.8%), itraconazole (69.5%), fluconazole (46.1%), ketoconazole (38.9%). Out of 131 evaluable patients, 34 (26.0%) died within 30 days from the onset of candidemia. C. tropicalis candidemia was associated with the highest mortality rate (44.7%). Regarding the crude mortality in the different units, patients in Hemato-Oncology ward had the highest mortality rate (66.7%), followed by patients in cardiovascular wards and ICU (57.1% and 25.6%, respectively). Predictors of 30-day mortality were identified by uni- and multivariate analyses. Complicated abdominal surgery, presence of central venous catheter (CVC), neutropenia, candidemia due to C. tropicalis and poor treatment with fluconazole were significantly associated with the 30-day mortality. Presence of CVC (odds ratio[OR] = 4.177; 95% confidence interval [CI] = 1.698 to 10.278; P = 0.002) was the only independent predictor for mortality in the multivariate analysis. CONCLUSION: This report provides baseline data for future epidemiological and susceptibility studies and for the mortality rates associated with candidemia in our hospital. The knowledge of the local epidemiological trends in Candida species isolated in blood cultures is important to guide therapeutic choices.
format Online
Article
Text
id pubmed-3723814
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37238142013-07-27 Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China Ma, Chun-fang Li, Fang-qiu Shi, Li-ning Hu, Yu-an Wang, Ying Huang, Mei Kong, Qian-qian BMC Infect Dis Research Article BACKGROUND: Bloodstream infections due to Candida species cause significant morbidity and mortality, and the epidemiology of Candida infection is changing. Surveillance for candidemia is necessary to detect trends in species distribution and antifungal resistance. METHODS: The medical and electronic records of all patients who had candidemia at the authors’ hospital from 2009 to 2011 were reviewed for demographic data and clinical information, including the infecting Candida species, resistance to antifungals and survival, and the presence of risk factors associated with candidemia. RESULTS: A total of 133 distinct episodes of candidemia were identified over the study period. The annual incidence of candidemia ranged between 0.71 and 0.85 cases/1000 hospital discharges. The most frequent Candida species were C. tropicalis (28.6%), followed by C. albicans (23.3%) and C. parapsilosis (19.5%). The rates of susceptibility to antifungal agents were as followed: voriconazole (97.8%), itraconazole (69.5%), fluconazole (46.1%), ketoconazole (38.9%). Out of 131 evaluable patients, 34 (26.0%) died within 30 days from the onset of candidemia. C. tropicalis candidemia was associated with the highest mortality rate (44.7%). Regarding the crude mortality in the different units, patients in Hemato-Oncology ward had the highest mortality rate (66.7%), followed by patients in cardiovascular wards and ICU (57.1% and 25.6%, respectively). Predictors of 30-day mortality were identified by uni- and multivariate analyses. Complicated abdominal surgery, presence of central venous catheter (CVC), neutropenia, candidemia due to C. tropicalis and poor treatment with fluconazole were significantly associated with the 30-day mortality. Presence of CVC (odds ratio[OR] = 4.177; 95% confidence interval [CI] = 1.698 to 10.278; P = 0.002) was the only independent predictor for mortality in the multivariate analysis. CONCLUSION: This report provides baseline data for future epidemiological and susceptibility studies and for the mortality rates associated with candidemia in our hospital. The knowledge of the local epidemiological trends in Candida species isolated in blood cultures is important to guide therapeutic choices. BioMed Central 2013-07-22 /pmc/articles/PMC3723814/ /pubmed/23875950 http://dx.doi.org/10.1186/1471-2334-13-337 Text en Copyright © 2013 Ma et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ma, Chun-fang
Li, Fang-qiu
Shi, Li-ning
Hu, Yu-an
Wang, Ying
Huang, Mei
Kong, Qian-qian
Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China
title Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China
title_full Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China
title_fullStr Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China
title_full_unstemmed Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China
title_short Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China
title_sort surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723814/
https://www.ncbi.nlm.nih.gov/pubmed/23875950
http://dx.doi.org/10.1186/1471-2334-13-337
work_keys_str_mv AT machunfang surveillancestudyofspeciesdistributionantifungalsusceptibilityandmortalityofnosocomialcandidemiainatertiarycarehospitalinchina
AT lifangqiu surveillancestudyofspeciesdistributionantifungalsusceptibilityandmortalityofnosocomialcandidemiainatertiarycarehospitalinchina
AT shilining surveillancestudyofspeciesdistributionantifungalsusceptibilityandmortalityofnosocomialcandidemiainatertiarycarehospitalinchina
AT huyuan surveillancestudyofspeciesdistributionantifungalsusceptibilityandmortalityofnosocomialcandidemiainatertiarycarehospitalinchina
AT wangying surveillancestudyofspeciesdistributionantifungalsusceptibilityandmortalityofnosocomialcandidemiainatertiarycarehospitalinchina
AT huangmei surveillancestudyofspeciesdistributionantifungalsusceptibilityandmortalityofnosocomialcandidemiainatertiarycarehospitalinchina
AT kongqianqian surveillancestudyofspeciesdistributionantifungalsusceptibilityandmortalityofnosocomialcandidemiainatertiarycarehospitalinchina